Trodelvy Archives - Express Pharma

Gilead gets US FDA Accelerated Approval for Trodelvy to treat metastatic urothelial cancer

Gilead gets US FDA nod for Trodelvy to treat metastatic triple-negative breast cancer

Trodelvy from Immunomedics gets US FDA orphan drug designation for glioblastoma

Trodelvy from Immunomedics extends survival in breast cancer patients

Gilead may soon buy Immunomedics in deal over $20 billion

FDA approves new therapy for triple negative breast cancer that has spread, not responded to other treatments